

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | indole-containing compound catabolic process (GO:0042436) | 5.86109972 |
| 2 | indolalkylamine catabolic process (GO:0046218) | 5.86109972 |
| 3 | tryptophan catabolic process (GO:0006569) | 5.86109972 |
| 4 | aromatic amino acid family catabolic process (GO:0009074) | 5.84133051 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.78106257 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.78106257 |
| 7 | tryptophan metabolic process (GO:0006568) | 5.73753282 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.11758810 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 5.11758810 |
| 10 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.92045167 |
| 11 | kynurenine metabolic process (GO:0070189) | 4.66365860 |
| 12 | cellular biogenic amine catabolic process (GO:0042402) | 4.65905910 |
| 13 | amine catabolic process (GO:0009310) | 4.65905910 |
| 14 | tyrosine metabolic process (GO:0006570) | 4.48264251 |
| 15 | urea cycle (GO:0000050) | 4.48111351 |
| 16 | urea metabolic process (GO:0019627) | 4.48111351 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.43223590 |
| 18 | indolalkylamine metabolic process (GO:0006586) | 4.40850849 |
| 19 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.35014937 |
| 20 | homocysteine metabolic process (GO:0050667) | 4.32669297 |
| 21 | rRNA catabolic process (GO:0016075) | 4.25593463 |
| 22 | aromatic amino acid family metabolic process (GO:0009072) | 4.23925761 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.19694671 |
| 24 | bile acid metabolic process (GO:0008206) | 4.06145072 |
| 25 | complement activation, alternative pathway (GO:0006957) | 4.02078666 |
| 26 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.95330191 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 3.94562298 |
| 28 | cysteine metabolic process (GO:0006534) | 3.92912983 |
| 29 | regulation of protein activation cascade (GO:2000257) | 3.91966891 |
| 30 | photoreceptor cell maintenance (GO:0045494) | 3.86051611 |
| 31 | regulation of bile acid biosynthetic process (GO:0070857) | 3.84031286 |
| 32 | NAD biosynthetic process (GO:0009435) | 3.81433574 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.80645338 |
| 34 | glyoxylate metabolic process (GO:0046487) | 3.78964215 |
| 35 | triglyceride homeostasis (GO:0070328) | 3.76779333 |
| 36 | acylglycerol homeostasis (GO:0055090) | 3.76779333 |
| 37 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.74474805 |
| 38 | bile acid and bile salt transport (GO:0015721) | 3.68486281 |
| 39 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.68409030 |
| 40 | protein carboxylation (GO:0018214) | 3.68409030 |
| 41 | cholesterol efflux (GO:0033344) | 3.63332847 |
| 42 | regulation of complement activation (GO:0030449) | 3.59092672 |
| 43 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.59029069 |
| 44 | serine family amino acid catabolic process (GO:0009071) | 3.58706211 |
| 45 | regulation of fibrinolysis (GO:0051917) | 3.56509913 |
| 46 | glycerophospholipid catabolic process (GO:0046475) | 3.56224147 |
| 47 | mitotic sister chromatid cohesion (GO:0007064) | 3.54448194 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 3.54259525 |
| 49 | negative regulation of lipase activity (GO:0060192) | 3.54233580 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 3.53637932 |
| 51 | reverse cholesterol transport (GO:0043691) | 3.52311944 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 3.50994783 |
| 53 | protein-lipid complex remodeling (GO:0034368) | 3.50994783 |
| 54 | macromolecular complex remodeling (GO:0034367) | 3.50994783 |
| 55 | neural tube formation (GO:0001841) | 3.49967804 |
| 56 | cellular glucuronidation (GO:0052695) | 3.48400868 |
| 57 | coenzyme catabolic process (GO:0009109) | 3.46718457 |
| 58 | negative regulation of fibrinolysis (GO:0051918) | 3.45650288 |
| 59 | establishment of protein localization to Golgi (GO:0072600) | 3.44484581 |
| 60 | phospholipid efflux (GO:0033700) | 3.43222751 |
| 61 | regulation of cholesterol esterification (GO:0010872) | 3.42423135 |
| 62 | ncRNA catabolic process (GO:0034661) | 3.40618612 |
| 63 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.36085248 |
| 64 | alpha-linolenic acid metabolic process (GO:0036109) | 3.34814255 |
| 65 | amino-acid betaine metabolic process (GO:0006577) | 3.34624432 |
| 66 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.30007290 |
| 67 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.30007290 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 3.29744807 |
| 69 | drug catabolic process (GO:0042737) | 3.26619866 |
| 70 | phospholipid homeostasis (GO:0055091) | 3.23394918 |
| 71 | epithelial cilium movement (GO:0003351) | 3.19777604 |
| 72 | DNA strand renaturation (GO:0000733) | 3.17776458 |
| 73 | centriole replication (GO:0007099) | 3.17593538 |
| 74 | negative regulation of protein activation cascade (GO:2000258) | 3.15229041 |
| 75 | retinal cone cell development (GO:0046549) | 3.14129408 |
| 76 | fucose catabolic process (GO:0019317) | 3.13541372 |
| 77 | L-fucose metabolic process (GO:0042354) | 3.13541372 |
| 78 | L-fucose catabolic process (GO:0042355) | 3.13541372 |
| 79 | presynaptic membrane assembly (GO:0097105) | 3.13277064 |
| 80 | opsonization (GO:0008228) | 3.13064094 |
| 81 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.11508812 |
| 82 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.11508812 |
| 83 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.11508812 |
| 84 | sulfur amino acid catabolic process (GO:0000098) | 3.10397160 |
| 85 | blood coagulation, intrinsic pathway (GO:0007597) | 3.08766948 |
| 86 | cellular amino acid catabolic process (GO:0009063) | 3.08154636 |
| 87 | glucuronate metabolic process (GO:0019585) | 3.07626999 |
| 88 | uronic acid metabolic process (GO:0006063) | 3.07626999 |
| 89 | protein targeting to Golgi (GO:0000042) | 3.05883965 |
| 90 | benzene-containing compound metabolic process (GO:0042537) | 3.05144541 |
| 91 | histone H3-K9 methylation (GO:0051567) | 3.03885276 |
| 92 | linoleic acid metabolic process (GO:0043651) | 3.01580411 |
| 93 | indole-containing compound metabolic process (GO:0042430) | 3.00679018 |
| 94 | valine metabolic process (GO:0006573) | 2.99315471 |
| 95 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.94595630 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 2.94266763 |
| 97 | low-density lipoprotein particle remodeling (GO:0034374) | 2.90886842 |
| 98 | cilium movement (GO:0003341) | 2.90760387 |
| 99 | response to pheromone (GO:0019236) | 2.84502855 |
| 100 | drug transmembrane transport (GO:0006855) | 2.83470807 |
| 101 | nucleotide transmembrane transport (GO:1901679) | 2.82716016 |
| 102 | kidney morphogenesis (GO:0060993) | 2.82672776 |
| 103 | arginine metabolic process (GO:0006525) | 2.81630151 |
| 104 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.81350502 |
| 105 | exogenous drug catabolic process (GO:0042738) | 2.81078636 |
| 106 | cellular ketone body metabolic process (GO:0046950) | 2.81017909 |
| 107 | protein activation cascade (GO:0072376) | 2.80580973 |
| 108 | fatty acid transmembrane transport (GO:1902001) | 2.80578063 |
| 109 | interkinetic nuclear migration (GO:0022027) | 2.79159751 |
| 110 | DNA damage induced protein phosphorylation (GO:0006975) | 2.78653335 |
| 111 | plasma lipoprotein particle organization (GO:0071827) | 2.78325581 |
| 112 | lysine catabolic process (GO:0006554) | 2.77822012 |
| 113 | lysine metabolic process (GO:0006553) | 2.77822012 |
| 114 | drug metabolic process (GO:0017144) | 2.77764395 |
| 115 | axoneme assembly (GO:0035082) | 2.77666840 |
| 116 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.76926014 |
| 117 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.76926014 |
| 118 | adenosine metabolic process (GO:0046085) | 2.76657294 |
| 119 | cholesterol homeostasis (GO:0042632) | 2.76355197 |
| 120 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.72779673 |
| 121 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.72164239 |
| 122 | plasma lipoprotein particle clearance (GO:0034381) | 2.71944839 |
| 123 | carnitine shuttle (GO:0006853) | 2.71233492 |
| 124 | protein localization to Golgi apparatus (GO:0034067) | 2.71023561 |
| 125 | nonmotile primary cilium assembly (GO:0035058) | 2.70726747 |
| 126 | androgen metabolic process (GO:0008209) | 2.70480248 |
| 127 | androgen biosynthetic process (GO:0006702) | 2.70365069 |
| 128 | cofactor catabolic process (GO:0051187) | 2.70117941 |
| 129 | presynaptic membrane organization (GO:0097090) | 2.68852255 |
| 130 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.68697136 |
| 131 | synapsis (GO:0007129) | 2.68645722 |
| 132 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.68507811 |
| 133 | sterol homeostasis (GO:0055092) | 2.67425211 |
| 134 | urate metabolic process (GO:0046415) | 2.67267891 |
| 135 | microtubule anchoring (GO:0034453) | 2.66394880 |
| 136 | organic acid catabolic process (GO:0016054) | 2.64925674 |
| 137 | carboxylic acid catabolic process (GO:0046395) | 2.64925674 |
| 138 | negative regulation of cholesterol transport (GO:0032375) | 2.64471650 |
| 139 | negative regulation of sterol transport (GO:0032372) | 2.64471650 |
| 140 | Golgi to endosome transport (GO:0006895) | 2.63359924 |
| 141 | replication fork processing (GO:0031297) | 2.62923837 |
| 142 | regulation of DNA endoreduplication (GO:0032875) | 2.60966327 |
| 143 | reciprocal meiotic recombination (GO:0007131) | 2.60737255 |
| 144 | reciprocal DNA recombination (GO:0035825) | 2.60737255 |
| 145 | protein K63-linked deubiquitination (GO:0070536) | 2.55480255 |
| 146 | histone mRNA catabolic process (GO:0071044) | 2.53773055 |
| 147 | sister chromatid cohesion (GO:0007062) | 2.53293395 |
| 148 | regulation of cilium movement (GO:0003352) | 2.52395022 |
| 149 | regulation of meiosis I (GO:0060631) | 2.50018943 |
| 150 | aspartate family amino acid catabolic process (GO:0009068) | 2.48090314 |
| 151 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.47812869 |
| 152 | neuron cell-cell adhesion (GO:0007158) | 2.45900432 |
| 153 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.45519424 |
| 154 | protein K11-linked deubiquitination (GO:0035871) | 2.44476184 |
| 155 | cilium organization (GO:0044782) | 2.44393857 |
| 156 | ketone body metabolic process (GO:1902224) | 2.43770478 |
| 157 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.42676787 |
| 158 | peptidyl-lysine trimethylation (GO:0018023) | 2.40898732 |
| 159 | nucleobase catabolic process (GO:0046113) | 2.40835562 |
| 160 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.40801123 |
| 161 | regulation of sarcomere organization (GO:0060297) | 2.40513391 |
| 162 | C4-dicarboxylate transport (GO:0015740) | 2.39628856 |
| 163 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.39584549 |
| 164 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.39584549 |
| 165 | histone H3-K9 modification (GO:0061647) | 2.39392113 |
| 166 | resolution of meiotic recombination intermediates (GO:0000712) | 2.38213315 |
| 167 | cellular response to sterol (GO:0036315) | 2.36370338 |
| 168 | histone H3-K4 trimethylation (GO:0080182) | 2.35983232 |
| 169 | carnitine transmembrane transport (GO:1902603) | 2.35646383 |
| 170 | cilium assembly (GO:0042384) | 2.34937452 |
| 171 | peptidyl-lysine methylation (GO:0018022) | 2.34664322 |
| 172 | amino-acid betaine transport (GO:0015838) | 2.33603534 |
| 173 | carnitine transport (GO:0015879) | 2.33603534 |
| 174 | polyol catabolic process (GO:0046174) | 2.33539332 |
| 175 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.33178746 |
| 176 | microtubule organizing center organization (GO:0031023) | 2.31476957 |
| 177 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.30516494 |
| 178 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.30367438 |
| 179 | DNA methylation involved in gamete generation (GO:0043046) | 2.30192829 |
| 180 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.29941815 |
| 181 | detection of light stimulus involved in visual perception (GO:0050908) | 2.29941815 |
| 182 | DNA double-strand break processing (GO:0000729) | 2.29853764 |
| 183 | nucleus localization (GO:0051647) | 2.28859454 |
| 184 | positive regulation of cation channel activity (GO:2001259) | 2.28585223 |
| 185 | reflex (GO:0060004) | 2.28452633 |
| 186 | intraciliary transport (GO:0042073) | 2.27409179 |
| 187 | regulation of centriole replication (GO:0046599) | 2.24550947 |
| 188 | gene silencing by RNA (GO:0031047) | 2.23612622 |
| 189 | cilium morphogenesis (GO:0060271) | 2.23120552 |
| 190 | regulation of glucokinase activity (GO:0033131) | 2.23079270 |
| 191 | regulation of hexokinase activity (GO:1903299) | 2.23079270 |
| 192 | protein targeting to vacuole (GO:0006623) | 2.21991390 |
| 193 | establishment of protein localization to vacuole (GO:0072666) | 2.21991390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.29695128 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.25825092 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.42809616 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.33199544 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.82901820 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.78885623 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.68666292 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.41214446 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.37855614 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.32514873 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.30027254 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.22294139 |
| 13 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.20645937 |
| 14 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.17456117 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.15938338 |
| 16 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.14443564 |
| 17 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.08426540 |
| 18 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.06416340 |
| 19 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.05497244 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.05005224 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.03597211 |
| 22 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.96689881 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.96416019 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.87754225 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.86614455 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.86322600 |
| 27 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.86188771 |
| 28 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.85564280 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82262724 |
| 30 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.81178362 |
| 31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.76999920 |
| 32 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.71040253 |
| 33 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.70801320 |
| 34 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.70493681 |
| 35 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.70493681 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.68688416 |
| 37 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.65233644 |
| 38 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.63718344 |
| 39 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.63120281 |
| 40 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.62672965 |
| 41 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.60519990 |
| 42 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.60365454 |
| 43 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.60306340 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.58860344 |
| 45 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.57883207 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57312289 |
| 47 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.53570723 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51861526 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50511006 |
| 50 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.50178305 |
| 51 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.48357479 |
| 52 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.46960788 |
| 53 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.46176528 |
| 54 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.45884000 |
| 55 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.45793607 |
| 56 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.44378622 |
| 57 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.44260344 |
| 58 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.42334448 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.42097336 |
| 60 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.40796466 |
| 61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.39408581 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39162331 |
| 63 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.39075094 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37954114 |
| 65 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.37715640 |
| 66 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.37386127 |
| 67 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.36410564 |
| 68 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.35093545 |
| 69 | EWS_26573619_Chip-Seq_HEK293_Human | 1.34549546 |
| 70 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.34147185 |
| 71 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.33958002 |
| 72 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32899057 |
| 73 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.32695528 |
| 74 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.31934803 |
| 75 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.31397958 |
| 76 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.29656142 |
| 77 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29205895 |
| 78 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.29175011 |
| 79 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.27568253 |
| 80 | TP53_16413492_ChIP-PET_HCT116_Human | 1.27254063 |
| 81 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.26624287 |
| 82 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.26422353 |
| 83 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.26011634 |
| 84 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.24793937 |
| 85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24298363 |
| 86 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.24298363 |
| 87 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.24256038 |
| 88 | VDR_22108803_ChIP-Seq_LS180_Human | 1.24195562 |
| 89 | TCF4_23295773_ChIP-Seq_U87_Human | 1.22668884 |
| 90 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21120520 |
| 91 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.18977257 |
| 92 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17531423 |
| 93 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17531423 |
| 94 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15945375 |
| 95 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14653247 |
| 96 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.13534546 |
| 97 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.13260977 |
| 98 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12649132 |
| 99 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12599014 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12419196 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11355879 |
| 102 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11063156 |
| 103 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10702302 |
| 104 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.10104345 |
| 105 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.09656882 |
| 106 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08110180 |
| 107 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.07755121 |
| 108 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07226386 |
| 109 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06605934 |
| 110 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06515047 |
| 111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06408467 |
| 112 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05977000 |
| 113 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05666147 |
| 114 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04759500 |
| 115 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.04409617 |
| 116 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04183803 |
| 117 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03569781 |
| 118 | AR_25329375_ChIP-Seq_VCAP_Human | 1.01879884 |
| 119 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01582518 |
| 120 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01562524 |
| 121 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01343225 |
| 122 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01000386 |
| 123 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00275104 |
| 124 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99450580 |
| 125 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99357599 |
| 126 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99289915 |
| 127 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.99288306 |
| 128 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98987163 |
| 129 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98759811 |
| 130 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97533391 |
| 131 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97477577 |
| 132 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.97443218 |
| 133 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.97313241 |
| 134 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97121349 |
| 135 | TBL1_22424771_ChIP-Seq_293T_Human | 0.96853221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.82352517 |
| 2 | MP0005360_urolithiasis | 5.52067072 |
| 3 | MP0005365_abnormal_bile_salt | 5.22568706 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.99950154 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.00476770 |
| 6 | MP0003252_abnormal_bile_duct | 3.44547246 |
| 7 | MP0009697_abnormal_copulation | 3.18203054 |
| 8 | MP0002009_preneoplasia | 3.03470394 |
| 9 | MP0003195_calcinosis | 2.80776921 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.49029983 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.42401350 |
| 12 | MP0005451_abnormal_body_composition | 2.25756759 |
| 13 | MP0003890_abnormal_embryonic-extraembry | 2.14301677 |
| 14 | MP0005332_abnormal_amino_acid | 2.09576225 |
| 15 | MP0006292_abnormal_olfactory_placode | 2.09187409 |
| 16 | MP0005408_hypopigmentation | 2.08486912 |
| 17 | MP0004043_abnormal_pH_regulation | 2.06341011 |
| 18 | MP0005646_abnormal_pituitary_gland | 2.00314674 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 1.98620235 |
| 20 | MP0002876_abnormal_thyroid_physiology | 1.97951969 |
| 21 | MP0000566_synostosis | 1.97446843 |
| 22 | MP0001764_abnormal_homeostasis | 1.90138167 |
| 23 | MP0005647_abnormal_sex_gland | 1.86478690 |
| 24 | MP0005253_abnormal_eye_physiology | 1.83600281 |
| 25 | MP0001501_abnormal_sleep_pattern | 1.81479914 |
| 26 | MP0003868_abnormal_feces_composition | 1.80895746 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 1.74536211 |
| 28 | MP0003283_abnormal_digestive_organ | 1.74333575 |
| 29 | MP0009046_muscle_twitch | 1.71445729 |
| 30 | MP0004885_abnormal_endolymph | 1.70979294 |
| 31 | MP0000383_abnormal_hair_follicle | 1.70355419 |
| 32 | MP0005171_absent_coat_pigmentation | 1.68646980 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.67682112 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.65393356 |
| 35 | MP0001984_abnormal_olfaction | 1.62892446 |
| 36 | MP0001968_abnormal_touch/_nociception | 1.61656021 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.59064339 |
| 38 | MP0001666_abnormal_nutrient_absorption | 1.58111127 |
| 39 | MP0005386_behavior/neurological_phenoty | 1.54747575 |
| 40 | MP0004924_abnormal_behavior | 1.54747575 |
| 41 | MP0004084_abnormal_cardiac_muscle | 1.53403607 |
| 42 | MP0000631_abnormal_neuroendocrine_gland | 1.52927573 |
| 43 | MP0005187_abnormal_penis_morphology | 1.52656353 |
| 44 | MP0002736_abnormal_nociception_after | 1.52306503 |
| 45 | MP0004215_abnormal_myocardial_fiber | 1.50687378 |
| 46 | MP0009764_decreased_sensitivity_to | 1.48831059 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.45273402 |
| 48 | MP0008058_abnormal_DNA_repair | 1.44114524 |
| 49 | MP0001529_abnormal_vocalization | 1.43600946 |
| 50 | MP0006072_abnormal_retinal_apoptosis | 1.41762353 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.41247124 |
| 52 | MP0000609_abnormal_liver_physiology | 1.40009639 |
| 53 | MP0004145_abnormal_muscle_electrophysio | 1.39746920 |
| 54 | MP0005670_abnormal_white_adipose | 1.34190395 |
| 55 | MP0002234_abnormal_pharynx_morphology | 1.31303238 |
| 56 | MP0002272_abnormal_nervous_system | 1.25192332 |
| 57 | MP0004381_abnormal_hair_follicle | 1.23632462 |
| 58 | MP0002160_abnormal_reproductive_system | 1.23443051 |
| 59 | MP0002653_abnormal_ependyma_morphology | 1.21922085 |
| 60 | MP0001485_abnormal_pinna_reflex | 1.21634443 |
| 61 | MP0009840_abnormal_foam_cell | 1.21544825 |
| 62 | MP0009745_abnormal_behavioral_response | 1.20425748 |
| 63 | MP0003937_abnormal_limbs/digits/tail_de | 1.19539704 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.19337824 |
| 65 | MP0002557_abnormal_social/conspecific_i | 1.19054496 |
| 66 | MP0010678_abnormal_skin_adnexa | 1.17217508 |
| 67 | MP0003787_abnormal_imprinting | 1.17043948 |
| 68 | MP0001986_abnormal_taste_sensitivity | 1.16750885 |
| 69 | MP0005083_abnormal_biliary_tract | 1.11997140 |
| 70 | MP0010094_abnormal_chromosome_stability | 1.11101452 |
| 71 | MP0002102_abnormal_ear_morphology | 1.10248551 |
| 72 | MP0008260_abnormal_autophagy | 1.08710932 |
| 73 | MP0009765_abnormal_xenobiotic_induced | 1.08496537 |
| 74 | MP0004742_abnormal_vestibular_system | 1.08239997 |
| 75 | MP0005645_abnormal_hypothalamus_physiol | 1.07984727 |
| 76 | MP0005334_abnormal_fat_pad | 1.07656829 |
| 77 | MP0002067_abnormal_sensory_capabilities | 1.06658790 |
| 78 | MP0003122_maternal_imprinting | 1.05218859 |
| 79 | MP0008995_early_reproductive_senescence | 1.04222620 |
| 80 | MP0001188_hyperpigmentation | 1.04087087 |
| 81 | MP0002229_neurodegeneration | 1.03310328 |
| 82 | MP0005266_abnormal_metabolism | 1.02418358 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 1.01992949 |
| 84 | MP0001177_atelectasis | 1.01658885 |
| 85 | MP0003950_abnormal_plasma_membrane | 1.01080482 |
| 86 | MP0003121_genomic_imprinting | 0.99615911 |
| 87 | MP0003690_abnormal_glial_cell | 0.99463781 |
| 88 | MP0009763_increased_sensitivity_to | 0.98102665 |
| 89 | MP0002572_abnormal_emotion/affect_behav | 0.97755788 |
| 90 | MP0001929_abnormal_gametogenesis | 0.97432818 |
| 91 | MP0002735_abnormal_chemical_nociception | 0.97389730 |
| 92 | MP0003880_abnormal_central_pattern | 0.97344779 |
| 93 | MP0000778_abnormal_nervous_system | 0.96793170 |
| 94 | MP0008872_abnormal_physiological_respon | 0.96060234 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.94807184 |
| 96 | MP0003119_abnormal_digestive_system | 0.94792401 |
| 97 | MP0004133_heterotaxia | 0.94645022 |
| 98 | MP0000579_abnormal_nail_morphology | 0.94411210 |
| 99 | MP0004085_abnormal_heartbeat | 0.94327282 |
| 100 | MP0003698_abnormal_male_reproductive | 0.94107774 |
| 101 | MP0003635_abnormal_synaptic_transmissio | 0.93234692 |
| 102 | MP0000647_abnormal_sebaceous_gland | 0.91935589 |
| 103 | MP0002064_seizures | 0.91701106 |
| 104 | MP0003011_delayed_dark_adaptation | 0.90019675 |
| 105 | MP0004130_abnormal_muscle_cell | 0.89581533 |
| 106 | MP0008775_abnormal_heart_ventricle | 0.89156302 |
| 107 | MP0005379_endocrine/exocrine_gland_phen | 0.88418041 |
| 108 | MP0002063_abnormal_learning/memory/cond | 0.88303833 |
| 109 | MP0004134_abnormal_chest_morphology | 0.88253522 |
| 110 | MP0000427_abnormal_hair_cycle | 0.88122550 |
| 111 | MP0003646_muscle_fatigue | 0.87385129 |
| 112 | MP0005551_abnormal_eye_electrophysiolog | 0.86804876 |
| 113 | MP0002638_abnormal_pupillary_reflex | 0.86517202 |
| 114 | MP0002909_abnormal_adrenal_gland | 0.86291967 |
| 115 | MP0009672_abnormal_birth_weight | 0.85839409 |
| 116 | MP0004036_abnormal_muscle_relaxation | 0.85475941 |
| 117 | MP0008789_abnormal_olfactory_epithelium | 0.84057669 |
| 118 | MP0003567_abnormal_fetal_cardiomyocyte | 0.82942126 |
| 119 | MP0005195_abnormal_posterior_eye | 0.82678838 |
| 120 | MP0002751_abnormal_autonomic_nervous | 0.81113835 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80340573 |
| 122 | MP0005391_vision/eye_phenotype | 0.79929955 |
| 123 | MP0003191_abnormal_cellular_cholesterol | 0.79908300 |
| 124 | MP0003943_abnormal_hepatobiliary_system | 0.79846234 |
| 125 | MP0000372_irregular_coat_pigmentation | 0.79563574 |
| 126 | MP0002822_catalepsy | 0.77917577 |
| 127 | MP0003718_maternal_effect | 0.77084603 |
| 128 | MP0008057_abnormal_DNA_replication | 0.76732030 |
| 129 | MP0002938_white_spotting | 0.76552479 |
| 130 | MP0004782_abnormal_surfactant_physiolog | 0.76527463 |
| 131 | MP0002882_abnormal_neuron_morphology | 0.75814759 |
| 132 | MP0004270_analgesia | 0.75501501 |
| 133 | MP0009703_decreased_birth_body | 0.75150525 |
| 134 | MP0002734_abnormal_mechanical_nocicepti | 0.74891042 |
| 135 | MP0010368_abnormal_lymphatic_system | 0.74715411 |
| 136 | MP0002752_abnormal_somatic_nervous | 0.74217790 |
| 137 | MP0005499_abnormal_olfactory_system | 0.73921260 |
| 138 | MP0005394_taste/olfaction_phenotype | 0.73921260 |
| 139 | MP0001661_extended_life_span | 0.73249638 |
| 140 | MP0001963_abnormal_hearing_physiology | 0.73201023 |
| 141 | MP0001119_abnormal_female_reproductive | 0.73095360 |
| 142 | MP0002132_abnormal_respiratory_system | 0.72499217 |
| 143 | MP0005389_reproductive_system_phenotype | 0.70398235 |
| 144 | MP0005220_abnormal_exocrine_pancreas | 0.70169952 |
| 145 | MP0001486_abnormal_startle_reflex | 0.69706848 |
| 146 | MP0000015_abnormal_ear_pigmentation | 0.69584275 |
| 147 | MP0009642_abnormal_blood_homeostasis | 0.69383534 |
| 148 | MP0000598_abnormal_liver_morphology | 0.69202277 |
| 149 | MP0001502_abnormal_circadian_rhythm | 0.67620701 |
| 150 | MP0003656_abnormal_erythrocyte_physiolo | 0.67329521 |
| 151 | MP0008877_abnormal_DNA_methylation | 0.66107155 |
| 152 | MP0000639_abnormal_adrenal_gland | 0.65775789 |
| 153 | MP0006276_abnormal_autonomic_nervous | 0.65532578 |
| 154 | MP0000371_diluted_coat_color | 0.63988589 |
| 155 | MP0008469_abnormal_protein_level | 0.63236626 |
| 156 | MP0010386_abnormal_urinary_bladder | 0.61684416 |
| 157 | MP0002971_abnormal_brown_adipose | 0.59545827 |
| 158 | MP0002249_abnormal_larynx_morphology | 0.59292436 |
| 159 | MP0009643_abnormal_urine_homeostasis | 0.58995692 |
| 160 | MP0003186_abnormal_redox_activity | 0.58471521 |
| 161 | MP0005248_abnormal_Harderian_gland | 0.57934849 |
| 162 | MP0002078_abnormal_glucose_homeostasis | 0.57852059 |
| 163 | MP0002928_abnormal_bile_duct | 0.57743728 |
| 164 | MP0001324_abnormal_eye_pigmentation | 0.57339687 |
| 165 | MP0004147_increased_porphyrin_level | 0.56149230 |
| 166 | MP0003953_abnormal_hormone_level | 0.55937075 |
| 167 | MP0005395_other_phenotype | 0.55615880 |
| 168 | MP0005409_darkened_coat_color | 0.55515994 |
| 169 | MP0002233_abnormal_nose_morphology | 0.54644629 |
| 170 | MP0001186_pigmentation_phenotype | 0.52450886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.44779195 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 4.94934573 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.55102431 |
| 4 | Joint hemorrhage (HP:0005261) | 4.38164687 |
| 5 | Epidermoid cyst (HP:0200040) | 4.02939114 |
| 6 | Deep venous thrombosis (HP:0002625) | 3.98194517 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 3.86536779 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.76341033 |
| 9 | Hypochromic microcytic anemia (HP:0004840) | 3.59357175 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 3.58514406 |
| 11 | Abnormality of methionine metabolism (HP:0010901) | 3.58483415 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.49513583 |
| 13 | Chronic hepatic failure (HP:0100626) | 3.46099931 |
| 14 | Xanthomatosis (HP:0000991) | 3.24950357 |
| 15 | Pancreatic cysts (HP:0001737) | 3.22410098 |
| 16 | Complement deficiency (HP:0004431) | 3.20412004 |
| 17 | Fair hair (HP:0002286) | 3.18342512 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.16668775 |
| 19 | Abnormality of the renal medulla (HP:0100957) | 3.12151772 |
| 20 | Nephronophthisis (HP:0000090) | 3.11282864 |
| 21 | Colon cancer (HP:0003003) | 3.06938118 |
| 22 | Stomach cancer (HP:0012126) | 3.05454704 |
| 23 | Abnormality of midbrain morphology (HP:0002418) | 3.05012658 |
| 24 | Molar tooth sign on MRI (HP:0002419) | 3.05012658 |
| 25 | Neoplasm of the adrenal cortex (HP:0100641) | 3.03611745 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.02825687 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.02560281 |
| 28 | Pancreatic fibrosis (HP:0100732) | 3.00485322 |
| 29 | Fat malabsorption (HP:0002630) | 2.99415586 |
| 30 | Volvulus (HP:0002580) | 2.97776975 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.93661463 |
| 32 | * Renal cortical cysts (HP:0000803) | 2.92223107 |
| 33 | Type II lissencephaly (HP:0007260) | 2.89091756 |
| 34 | Cerebellar dysplasia (HP:0007033) | 2.88555384 |
| 35 | Gaze-evoked nystagmus (HP:0000640) | 2.88120126 |
| 36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.86139413 |
| 37 | Prostate neoplasm (HP:0100787) | 2.82866145 |
| 38 | Osteomalacia (HP:0002749) | 2.82795567 |
| 39 | Hypoglycemic seizures (HP:0002173) | 2.78821642 |
| 40 | Proximal tubulopathy (HP:0000114) | 2.72829389 |
| 41 | Hypolipoproteinemia (HP:0010981) | 2.72305420 |
| 42 | Hypoglycemic coma (HP:0001325) | 2.69798945 |
| 43 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.69455591 |
| 44 | Abnormality of the common coagulation pathway (HP:0010990) | 2.67758385 |
| 45 | Hyperventilation (HP:0002883) | 2.64649279 |
| 46 | Generalized hypopigmentation of hair (HP:0011358) | 2.61085624 |
| 47 | Enlarged kidneys (HP:0000105) | 2.58897579 |
| 48 | Hypoalphalipoproteinemia (HP:0003233) | 2.58128073 |
| 49 | Hypercholesterolemia (HP:0003124) | 2.55074137 |
| 50 | Chromsome breakage (HP:0040012) | 2.52275223 |
| 51 | Tubulointerstitial nephritis (HP:0001970) | 2.51460786 |
| 52 | Hepatoblastoma (HP:0002884) | 2.50753646 |
| 53 | Abnormality of the intrinsic pathway (HP:0010989) | 2.50618161 |
| 54 | Hyperglycinemia (HP:0002154) | 2.41540895 |
| 55 | Hyperglycinuria (HP:0003108) | 2.40713170 |
| 56 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.38204036 |
| 57 | Absent/shortened dynein arms (HP:0200106) | 2.38204036 |
| 58 | Symptomatic seizures (HP:0011145) | 2.35834501 |
| 59 | Steatorrhea (HP:0002570) | 2.35070403 |
| 60 | Gingival bleeding (HP:0000225) | 2.27522981 |
| 61 | Spontaneous abortion (HP:0005268) | 2.26465885 |
| 62 | Drooling (HP:0002307) | 2.25142732 |
| 63 | Glioma (HP:0009733) | 2.23609411 |
| 64 | Alveolar cell carcinoma (HP:0006519) | 2.23164325 |
| 65 | True hermaphroditism (HP:0010459) | 2.22724531 |
| 66 | Abnormality of the prostate (HP:0008775) | 2.19591747 |
| 67 | Pigmentary retinal degeneration (HP:0001146) | 2.18895668 |
| 68 | Vascular calcification (HP:0004934) | 2.18407533 |
| 69 | Progressive inability to walk (HP:0002505) | 2.16499531 |
| 70 | Abnormal hair whorl (HP:0010721) | 2.13492273 |
| 71 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.13383898 |
| 72 | Congenital stationary night blindness (HP:0007642) | 2.12700859 |
| 73 | Neoplasm of the oral cavity (HP:0100649) | 2.11715892 |
| 74 | Hyperkalemia (HP:0002153) | 2.11305631 |
| 75 | Tubular atrophy (HP:0000092) | 2.10314621 |
| 76 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.10038334 |
| 77 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.10038334 |
| 78 | Hypophosphatemic rickets (HP:0004912) | 2.09142506 |
| 79 | Widely spaced teeth (HP:0000687) | 2.09016292 |
| 80 | Blue irides (HP:0000635) | 2.08951468 |
| 81 | Inability to walk (HP:0002540) | 2.08444617 |
| 82 | Hypoplastic ischia (HP:0003175) | 2.07231436 |
| 83 | Broad-based gait (HP:0002136) | 2.06130206 |
| 84 | Abnormality of serum amino acid levels (HP:0003112) | 2.06029819 |
| 85 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.05014937 |
| 86 | Abnormality of glycine metabolism (HP:0010895) | 2.05014937 |
| 87 | Bile duct proliferation (HP:0001408) | 2.04199120 |
| 88 | Abnormal biliary tract physiology (HP:0012439) | 2.04199120 |
| 89 | Abnormal drinking behavior (HP:0030082) | 2.03121865 |
| 90 | Polydipsia (HP:0001959) | 2.03121865 |
| 91 | Abnormality of nucleobase metabolism (HP:0010932) | 2.02552142 |
| 92 | Cystic liver disease (HP:0006706) | 2.02317875 |
| 93 | Astrocytoma (HP:0009592) | 2.00694290 |
| 94 | Abnormality of the astrocytes (HP:0100707) | 2.00694290 |
| 95 | Thyroid-stimulating hormone excess (HP:0002925) | 2.00527498 |
| 96 | Abnormality of the ischium (HP:0003174) | 2.00265304 |
| 97 | Excessive salivation (HP:0003781) | 1.99544246 |
| 98 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.99044039 |
| 99 | Abnormality of complement system (HP:0005339) | 1.97659420 |
| 100 | * Abnormality of the renal cortex (HP:0011035) | 1.97462425 |
| 101 | Febrile seizures (HP:0002373) | 1.97435397 |
| 102 | Genetic anticipation (HP:0003743) | 1.97247956 |
| 103 | Hyperammonemia (HP:0001987) | 1.97195610 |
| 104 | Intestinal atresia (HP:0011100) | 1.95921984 |
| 105 | Myocardial infarction (HP:0001658) | 1.95126209 |
| 106 | Abnormality of the labia minora (HP:0012880) | 1.95056879 |
| 107 | Poor coordination (HP:0002370) | 1.95019696 |
| 108 | Lissencephaly (HP:0001339) | 1.94133551 |
| 109 | Attenuation of retinal blood vessels (HP:0007843) | 1.93878909 |
| 110 | Ketosis (HP:0001946) | 1.93534719 |
| 111 | Neonatal hypoglycemia (HP:0001998) | 1.93407669 |
| 112 | Decreased circulating renin level (HP:0003351) | 1.93100306 |
| 113 | Thyroid carcinoma (HP:0002890) | 1.91044122 |
| 114 | Abnormal ciliary motility (HP:0012262) | 1.90270504 |
| 115 | Abnormality of incisor morphology (HP:0011063) | 1.89819785 |
| 116 | Genital tract atresia (HP:0001827) | 1.89755852 |
| 117 | Tubulointerstitial abnormality (HP:0001969) | 1.88993840 |
| 118 | Patchy hypopigmentation of hair (HP:0011365) | 1.88214136 |
| 119 | Generalized aminoaciduria (HP:0002909) | 1.88039977 |
| 120 | Medulloblastoma (HP:0002885) | 1.86130797 |
| 121 | Microvesicular hepatic steatosis (HP:0001414) | 1.85993959 |
| 122 | Absent speech (HP:0001344) | 1.85917804 |
| 123 | Hypoplastic iliac wings (HP:0002866) | 1.85689701 |
| 124 | Opisthotonus (HP:0002179) | 1.85436592 |
| 125 | Congenital hepatic fibrosis (HP:0002612) | 1.84925259 |
| 126 | Hydroxyprolinuria (HP:0003080) | 1.84912359 |
| 127 | Abnormality of proline metabolism (HP:0010907) | 1.84912359 |
| 128 | Hyperbilirubinemia (HP:0002904) | 1.84298952 |
| 129 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.83538961 |
| 130 | Oligodactyly (hands) (HP:0001180) | 1.83098092 |
| 131 | Truncal obesity (HP:0001956) | 1.82326511 |
| 132 | Mitral stenosis (HP:0001718) | 1.81896085 |
| 133 | Abnormality of chromosome stability (HP:0003220) | 1.81091788 |
| 134 | White forelock (HP:0002211) | 1.80955575 |
| 135 | Papillary thyroid carcinoma (HP:0002895) | 1.80783449 |
| 136 | Birth length less than 3rd percentile (HP:0003561) | 1.79782865 |
| 137 | Polyuria (HP:0000103) | 1.78000327 |
| 138 | Vaginal atresia (HP:0000148) | 1.77703164 |
| 139 | Hypoplasia of the fovea (HP:0007750) | 1.77348244 |
| 140 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.77348244 |
| 141 | Cardiovascular calcification (HP:0011915) | 1.77295378 |
| 142 | Hyperglycemia (HP:0003074) | 1.75541888 |
| 143 | Abnormality of potassium homeostasis (HP:0011042) | 1.75251859 |
| 144 | * Abnormality of fatty-acid metabolism (HP:0004359) | 1.75086730 |
| 145 | * Abnormal biliary tract morphology (HP:0012440) | 1.74679667 |
| 146 | Nephrogenic diabetes insipidus (HP:0009806) | 1.74459999 |
| 147 | Postaxial foot polydactyly (HP:0001830) | 1.74379771 |
| 148 | Abnormality of the fingertips (HP:0001211) | 1.73430035 |
| 149 | Medial flaring of the eyebrow (HP:0010747) | 1.73199770 |
| 150 | Arthropathy (HP:0003040) | 1.72958293 |
| 151 | Epileptic encephalopathy (HP:0200134) | 1.72478647 |
| 152 | Partial agenesis of the corpus callosum (HP:0001338) | 1.72271847 |
| 153 | Confusion (HP:0001289) | 1.71962902 |
| 154 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.71261290 |
| 155 | Hypoplastic labia majora (HP:0000059) | 1.70287229 |
| 156 | Congenital primary aphakia (HP:0007707) | 1.70174400 |
| 157 | Optic neuritis (HP:0100653) | 1.69731126 |
| 158 | Retrobulbar optic neuritis (HP:0100654) | 1.69731126 |
| 159 | Delayed CNS myelination (HP:0002188) | 1.69628546 |
| 160 | Rickets (HP:0002748) | 1.69569458 |
| 161 | Hepatocellular carcinoma (HP:0001402) | 1.69283380 |
| 162 | Systemic lupus erythematosus (HP:0002725) | 1.68534859 |
| 163 | Gastrointestinal atresia (HP:0002589) | 1.68450356 |
| 164 | Progressive cerebellar ataxia (HP:0002073) | 1.68083727 |
| 165 | * Prolonged neonatal jaundice (HP:0006579) | 1.66677310 |
| 166 | Clumsiness (HP:0002312) | 1.66654542 |
| 167 | Abnormality of homocysteine metabolism (HP:0010919) | 1.65855507 |
| 168 | Homocystinuria (HP:0002156) | 1.65855507 |
| 169 | Abnormality of the pons (HP:0007361) | 1.65247298 |
| 170 | Abolished electroretinogram (ERG) (HP:0000550) | 1.64969880 |
| 171 | Calf muscle hypertrophy (HP:0008981) | 1.64673174 |
| 172 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.63447426 |
| 173 | Hypoplasia of the pons (HP:0012110) | 1.63286004 |
| 174 | Gait imbalance (HP:0002141) | 1.62927781 |
| 175 | Abnormal pancreas size (HP:0012094) | 1.62431877 |
| 176 | Abnormality of chloride homeostasis (HP:0011422) | 1.62303299 |
| 177 | * Protruding tongue (HP:0010808) | 1.62211583 |
| 178 | Hyperaldosteronism (HP:0000859) | 1.61168352 |
| 179 | Sloping forehead (HP:0000340) | 1.60620893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 3.05797082 |
| 2 | CASK | 2.99006840 |
| 3 | MAP3K14 | 2.62277653 |
| 4 | EIF2AK2 | 2.51051711 |
| 5 | CAMK1G | 2.46622676 |
| 6 | NUAK1 | 2.45198743 |
| 7 | WNK3 | 2.40239468 |
| 8 | MAP2K7 | 2.36447370 |
| 9 | MAP4K2 | 2.28816300 |
| 10 | BRD4 | 2.18155801 |
| 11 | TAOK3 | 2.14331510 |
| 12 | SGK2 | 2.14005890 |
| 13 | ZAK | 2.11650390 |
| 14 | STK38L | 2.09257122 |
| 15 | MAP2K4 | 2.07353022 |
| 16 | CAMK1D | 1.99472452 |
| 17 | MAP3K13 | 1.82382591 |
| 18 | MAP3K4 | 1.78664890 |
| 19 | LATS1 | 1.75187088 |
| 20 | MAP3K7 | 1.74993454 |
| 21 | OBSCN | 1.70882766 |
| 22 | AKT3 | 1.64100824 |
| 23 | SGK494 | 1.61777989 |
| 24 | SGK223 | 1.61777989 |
| 25 | CAMKK2 | 1.60108214 |
| 26 | BMPR1B | 1.55677753 |
| 27 | BMPR2 | 1.52833214 |
| 28 | CDK3 | 1.51483103 |
| 29 | ERBB4 | 1.48413877 |
| 30 | IRAK4 | 1.46271697 |
| 31 | IRAK3 | 1.42122311 |
| 32 | SGK3 | 1.40124728 |
| 33 | PINK1 | 1.35206494 |
| 34 | PRPF4B | 1.34081147 |
| 35 | FRK | 1.33717886 |
| 36 | WNK4 | 1.31796648 |
| 37 | ERBB3 | 1.30087552 |
| 38 | NEK6 | 1.29849561 |
| 39 | PIK3CA | 1.25836790 |
| 40 | SIK1 | 1.23568067 |
| 41 | CSNK1G2 | 1.17206651 |
| 42 | CSNK1G1 | 1.16593499 |
| 43 | EIF2AK1 | 1.16023816 |
| 44 | TNK2 | 1.15890352 |
| 45 | BRSK2 | 1.12328329 |
| 46 | YES1 | 1.11877285 |
| 47 | MKNK2 | 1.10705403 |
| 48 | EPHA3 | 1.09515788 |
| 49 | PNCK | 1.08213967 |
| 50 | EIF2AK3 | 1.07309661 |
| 51 | NTRK3 | 1.06459163 |
| 52 | NEK2 | 1.06427070 |
| 53 | MARK1 | 1.05532559 |
| 54 | EPHA4 | 1.05059805 |
| 55 | TXK | 1.04112476 |
| 56 | CSNK1G3 | 1.03461796 |
| 57 | NTRK2 | 1.02587812 |
| 58 | MKNK1 | 1.02579356 |
| 59 | TNIK | 0.99207379 |
| 60 | SCYL2 | 0.98650872 |
| 61 | SIK3 | 0.96578631 |
| 62 | CDK8 | 0.94524382 |
| 63 | MAP2K6 | 0.92433307 |
| 64 | FGFR2 | 0.91788100 |
| 65 | PLK4 | 0.89859544 |
| 66 | STK39 | 0.88874944 |
| 67 | MAP2K3 | 0.88784967 |
| 68 | KIT | 0.88350401 |
| 69 | PHKG2 | 0.84469209 |
| 70 | PHKG1 | 0.84469209 |
| 71 | ATM | 0.83561893 |
| 72 | PKN1 | 0.83213751 |
| 73 | BCR | 0.82544328 |
| 74 | STK3 | 0.82264171 |
| 75 | MAPK7 | 0.81677636 |
| 76 | TGFBR1 | 0.81160906 |
| 77 | MET | 0.80787538 |
| 78 | MAPK13 | 0.80463271 |
| 79 | CHUK | 0.79650288 |
| 80 | EEF2K | 0.79582706 |
| 81 | FGFR4 | 0.78731441 |
| 82 | MST1R | 0.77314823 |
| 83 | IKBKE | 0.77028727 |
| 84 | PRKAA2 | 0.75921629 |
| 85 | TEC | 0.75379259 |
| 86 | PASK | 0.72400290 |
| 87 | PAK3 | 0.69483386 |
| 88 | RPS6KB2 | 0.69296494 |
| 89 | BCKDK | 0.69068353 |
| 90 | WNK1 | 0.68411278 |
| 91 | IRAK2 | 0.66842849 |
| 92 | TIE1 | 0.64199767 |
| 93 | DYRK1A | 0.63518490 |
| 94 | SRPK1 | 0.62431731 |
| 95 | CSNK1D | 0.60876784 |
| 96 | MAPKAPK5 | 0.59878154 |
| 97 | GRK1 | 0.59627013 |
| 98 | CAMKK1 | 0.59449869 |
| 99 | IKBKB | 0.59152291 |
| 100 | STK11 | 0.59088791 |
| 101 | MAPK12 | 0.58213562 |
| 102 | VRK1 | 0.57905934 |
| 103 | ADRBK2 | 0.56977198 |
| 104 | CAMK4 | 0.56424586 |
| 105 | RPS6KB1 | 0.56193679 |
| 106 | CDK12 | 0.56001348 |
| 107 | SGK1 | 0.55966077 |
| 108 | DAPK2 | 0.55246059 |
| 109 | PIK3CG | 0.54883639 |
| 110 | PRKCQ | 0.54664833 |
| 111 | FGFR3 | 0.50996886 |
| 112 | IRAK1 | 0.50827323 |
| 113 | JAK1 | 0.50260287 |
| 114 | PRKCE | 0.50203816 |
| 115 | ATR | 0.49963408 |
| 116 | ACVR1B | 0.49494752 |
| 117 | PRKDC | 0.49291220 |
| 118 | STK38 | 0.48468036 |
| 119 | MAPK11 | 0.48466758 |
| 120 | NLK | 0.48104210 |
| 121 | JAK3 | 0.47570457 |
| 122 | MUSK | 0.47090823 |
| 123 | PRKAA1 | 0.46345769 |
| 124 | CSNK1E | 0.46205339 |
| 125 | OXSR1 | 0.44632890 |
| 126 | CAMK2A | 0.43895332 |
| 127 | PLK2 | 0.43836047 |
| 128 | DYRK2 | 0.43598614 |
| 129 | CSNK1A1L | 0.43550102 |
| 130 | RPS6KA4 | 0.42552801 |
| 131 | CSF1R | 0.42526174 |
| 132 | MAPK10 | 0.41904705 |
| 133 | MAP3K6 | 0.41580661 |
| 134 | CCNB1 | 0.41542352 |
| 135 | TRPM7 | 0.41209749 |
| 136 | CHEK2 | 0.40358455 |
| 137 | CLK1 | 0.36912254 |
| 138 | CDK9 | 0.36728404 |
| 139 | FLT3 | 0.36441640 |
| 140 | PRKCZ | 0.35455889 |
| 141 | PLK3 | 0.34230212 |
| 142 | CAMK1 | 0.33103597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.09260689 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.97958843 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.79771371 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71895540 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65514718 |
| 6 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.47622307 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.31697208 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.26292265 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.24373643 |
| 10 | * Peroxisome_Homo sapiens_hsa04146 | 2.22065543 |
| 11 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.21396724 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.21026875 |
| 13 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.19574751 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16068439 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.14438142 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.07465633 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.04539064 |
| 18 | Retinol metabolism_Homo sapiens_hsa00830 | 2.01976097 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.00920262 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.00918920 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92117827 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90728885 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86946233 |
| 24 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.85355072 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.80294696 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.74731238 |
| 27 | ABC transporters_Homo sapiens_hsa02010 | 1.74220624 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73548624 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.67136620 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.62693509 |
| 31 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.61130725 |
| 32 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.58978069 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.54698400 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.53245294 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.50682460 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.47146285 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44735310 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41570309 |
| 39 | Olfactory transduction_Homo sapiens_hsa04740 | 1.38452624 |
| 40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.35527202 |
| 41 | Lysine degradation_Homo sapiens_hsa00310 | 1.35483647 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32888612 |
| 43 | RNA degradation_Homo sapiens_hsa03018 | 1.32851777 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29921961 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.23712814 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23609579 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15997930 |
| 48 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.09166484 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 1.07884609 |
| 50 | Circadian entrainment_Homo sapiens_hsa04713 | 1.07800198 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 1.05869401 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03063302 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.98931434 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.95353229 |
| 55 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.94985067 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94309598 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92943029 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91676052 |
| 59 | GABAergic synapse_Homo sapiens_hsa04727 | 0.88628850 |
| 60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.87753998 |
| 61 | Renin secretion_Homo sapiens_hsa04924 | 0.87261202 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87236535 |
| 63 | Long-term depression_Homo sapiens_hsa04730 | 0.85078809 |
| 64 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.83355748 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.82688609 |
| 66 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.81547460 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78122479 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77041823 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75868297 |
| 70 | Morphine addiction_Homo sapiens_hsa05032 | 0.75550341 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75099584 |
| 72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74960263 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74206630 |
| 74 | Salivary secretion_Homo sapiens_hsa04970 | 0.70742607 |
| 75 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.70523131 |
| 76 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.70239329 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.69393685 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67560241 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66527137 |
| 80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64709927 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63706649 |
| 82 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62499606 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61348966 |
| 84 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.59607918 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59530742 |
| 86 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.58678540 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58114928 |
| 88 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.57755513 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.57579060 |
| 90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57199210 |
| 91 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.56482817 |
| 92 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52894877 |
| 93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52263214 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52171149 |
| 95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49885129 |
| 96 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49627390 |
| 97 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49370168 |
| 98 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48812386 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.48386946 |
| 100 | Protein export_Homo sapiens_hsa03060 | 0.48358392 |
| 101 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48219127 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46264160 |
| 103 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46163737 |
| 104 | Purine metabolism_Homo sapiens_hsa00230 | 0.45962347 |
| 105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44998159 |
| 106 | RNA transport_Homo sapiens_hsa03013 | 0.44168822 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43672676 |
| 108 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.43591611 |
| 109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43384541 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43121427 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42420985 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33067498 |
| 113 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.31445878 |
| 114 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.31438456 |
| 115 | Nicotine addiction_Homo sapiens_hsa05033 | 0.29316995 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.28623896 |
| 117 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25691376 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21905500 |
| 119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.21576351 |
| 120 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.21022406 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | 0.19754789 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.19511167 |
| 123 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.17802097 |
| 124 | Basal transcription factors_Homo sapiens_hsa03022 | 0.17796028 |
| 125 | Taste transduction_Homo sapiens_hsa04742 | 0.17777102 |
| 126 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17515534 |
| 127 | Homologous recombination_Homo sapiens_hsa03440 | 0.16394028 |
| 128 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.15472047 |
| 129 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.14829369 |
| 130 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.14570993 |
| 131 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13859303 |
| 132 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.13701914 |
| 133 | Phototransduction_Homo sapiens_hsa04744 | 0.13369209 |
| 134 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.12687630 |
| 135 | Influenza A_Homo sapiens_hsa05164 | 0.11932245 |
| 136 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.11574292 |
| 137 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.10709267 |
| 138 | Allograft rejection_Homo sapiens_hsa05330 | 0.10427174 |
| 139 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.06109114 |
| 140 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.04390840 |
| 141 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.04116539 |

